Display options
Share it on

Indian J Palliat Care. 2016 Jul-Sep;22(3):295-300. doi: 10.4103/0973-1075.185039.

The Efficacy of Oral Melatonin in Improving Sleep in Cancer Patients with Insomnia: A Randomized Double-Blind Placebo-Controlled Study.

Indian journal of palliative care

Madhuri S Kurdi, Sindhu Priya Muthukalai

Affiliations

  1. Department of Anaesthesiology, Karnataka Institute of Medical Sciences, Hubli, Karnataka, India.

PMID: 27559258 PMCID: PMC4973490 DOI: 10.4103/0973-1075.185039

Abstract

BACKGROUND: The natural hormone melatonin has sleep inducing properties. Insomnia in cancer patients is common. So far, melatonin has been seldom tried for the improvement of sleep in patients with malignancies. Keeping this in mind, we planned and conducted a double-blind study to test the efficacy of melatonin in promoting sleep in patients with malignancies suffering from insomnia.

OBJECTIVE: To assess the hypnotic efficacy of oral melatonin in cancer patients with insomnia.

MATERIALS AND METHODS: After Ethical Committee approval, 50 patients (age range 20-65 years) from our pain clinic NIVARANE who met the Diagnostic and Statistical Manual of Mental Disorders 4(th) edition criteria for primary insomnia were randomized to receive melatonin 3 mg or placebo at 7 pm orally every day for 14 days from our pharmacist. After 1, 7, 14 days, the patients were reviewed with the Athens insomnia scale oral questionnaire to document the subjective sleep quality. The patients and we, the investigators were blinded to the study drug.

RESULTS: There were 2 drop outs (one from each group) as they failed to complete visit on day 14. Significant differences in favor of melatonin treatment were found in clinically relevant improvements in insomnia (46.53%; P = 0.00001 vs. 11.30%; P = 0.1026) There was improvement in sleep from 1 to 7 days (19.91%; P = 0.00001 vs. 0.98%; P = 0.2563). More significant improvements were seen between 7 and 14 days (33.24%; P = 0.00001 vs. 10.42%; P = 0.1469).

CONCLUSION: We conclude that daily intake of oral melatonin 2 h before bedtime improves sleep induction and quality in cancer patients with insomnia.

Keywords: Malignancies; Melatonin; Oral administration; Sleep; Sleep disorders

References

  1. J Am Board Fam Pract. 2004 May-Jun;17(3):212-9 - PubMed
  2. Ther Clin Risk Manag. 2011;7:301-11 - PubMed
  3. Ann Oncol. 2014 Apr;25(4):791-800 - PubMed
  4. J Pineal Res. 2007 Jan;42(1):12-21 - PubMed
  5. Curr Med Res Opin. 2007 Oct;23(10):2597-605 - PubMed
  6. J Pineal Res. 2012 May;52(4):365-75 - PubMed
  7. J Sleep Res. 1996 Mar;5(1):61-5 - PubMed
  8. Support Care Cancer. 2016 Mar;24(3):1097-105 - PubMed
  9. Aging Clin Exp Res. 2013 Oct;25(5):499-510 - PubMed
  10. J Psychosom Res. 2003 Sep;55(3):263-7 - PubMed
  11. PLoS One. 2013 May 17;8(5):e63773 - PubMed
  12. J Psychiatry Neurosci. 2003 May;28(3):191-6 - PubMed
  13. Indian J Anaesth. 2013 Mar;57(2):137-44 - PubMed
  14. Sleep. 1995 Sep;18(7):598-603 - PubMed
  15. Anesthesiology. 2009 Jul;111(1):44-9 - PubMed
  16. J Pineal Res. 2011 Oct;51(3):270-7 - PubMed
  17. J Anaesthesiol Clin Pharmacol. 2015 Jan-Mar;31(1):37-43 - PubMed
  18. Nat Sci Sleep. 2015 Jan 29;7:13-23 - PubMed
  19. J Support Oncol. 2005 Sep-Oct;3(5):349-59 - PubMed
  20. Anaesth Intensive Care. 2011 Mar;39(2):171-81 - PubMed
  21. Sleep Med Rev. 2006 Dec;10(6):419-29 - PubMed
  22. Acta Neurol Scand. 2004 Jul;110(1):6-13 - PubMed
  23. Cancer Med. 2015 Feb;4(2):183-200 - PubMed
  24. PLoS One. 2014 Oct 02;9(9):e108614 - PubMed

Publication Types